EichorEICHOR
Location: Haifa Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Haifa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Rambam Health Care Campus-Oncology ( Site 0076) · Merck Sharp & Dohme LLC · NCT04165070Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Rambam Health Care Campus · Pfizer · NCT07028853Comparative Research of Y-Incision vs. Standard Techniques for Aortic Root EnLargement
NA · Rambam Health Care Campus · willner nadav MD · NCT07368322A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Rambam Health Care Campus-Hematology and Bone Marrow Transpl · Merck Sharp & Dohme LLC · NCT06136559Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Rambam Health Care Campus · Bristol-Myers Squibb · NCT07106762A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Rambam Health Care Campus · Pfizer · NCT07206225A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Rambam Health Care Campus · Eli Lilly and Company · NCT07483099LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Rambam Health Care Campus · Eli Lilly and Company · NCT07415044A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Rambam Health Care Campus ( Site 1907) · Merck Sharp & Dohme LLC · NCT07216703International Rare Brain Tumor Registry
Phase N/A · Rambam Health Care Campus · Children's National Research Institute · NCT05697874A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Rambam Health Care Campus · Eli Lilly and Company · NCT06890598A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Rambam Health Corporation · Bayer · NCT07192952A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Rambam Health Care Campus · Eli Lilly and Company · NCT07222332A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Bnai Zion Medical Center · Regeneron Pharmaceuticals · NCT06091865A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · Rambam Health Care Campus ( Site 0252) · Merck Sharp & Dohme LLC · NCT07247110A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Rambam Health Care Campus · Pfizer · NCT07470879Validating and Evaluating the Pain Medicine Digital Workflow Algorithm (PGS 1.0)
Phase N/A · Pain Medicine Institute, Rambam Health Care Campus · PG Medical Systems Ltd. · NCT07195162Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Rambam Health Care Campus · Eli Lilly and Company · NCT06937086The Effect of Temporary Ovarian Suspension to the Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion
NA · Carmel Medical Center · Carmel Medical Center · NCT07087756A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Lady Davis Carmel Medical Center · UroGen Pharma Ltd. · NCT06774131Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery
NA · Rambam Medical Center · Rambam Health Care Campus · NCT07714902A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0192 · Celgene · NCT05519085Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Lady Davis Carmel Medical Center · Gilead Sciences · NCT06051617Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Phase 1 · Rambam Health Care Campus · Gilead Sciences · NCT06167317A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 · Rambam Medical Center · Janssen Research & Development, LLC · NCT04634552A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Rambam Health Care Campus ( Site 1600) · Merck Sharp & Dohme LLC · NCT07489495POST URS Chemotherapy Instillation
NA · Bnai Zion Medical Center · Carmel Medical Center · NCT06167057
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.